tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (DE:IQT0)
MUNICH:IQT0

Inhibikase Therapeutics (IQT0) Revenue

Compare
1 Followers

Inhibikase Therapeutics Revenue

Inhibikase Therapeutics had a revenue of 0.00 in the quarter ending Mar 31, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Inhibikase Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
15
Market Cap
$106.12M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
0.00-260.50K-100.00%
Dec 31, 2023
260.50K137.06K+111.03%
Dec 31, 2022
123.44K-2.98M-96.02%
Dec 31, 2021
3.10M2.40M+343.92%
Dec 31, 2020
698.47K-424.27K-37.79%
Dec 31, 2019
1.12M-2.92M-72.22%
Dec 31, 2018
4.04M1.98M+96.07%
Dec 31, 2017
2.06M1.09M+113.04%
Dec 31, 2016
967.39K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis